Bik To

570 total citations
18 papers, 424 citations indexed

About

Bik To is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Bik To has authored 18 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Bik To's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Bik To is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Bik To collaborates with scholars based in Australia, United States and Sweden. Bik To's co-authors include Kate Cameron, Sally Borbasi, Ian Olver, David Evans, C. Glenn Begley, Jeff Szer, Timothy P. Hughes, Peter Bardy, Andrew Grigg and Anthony P. Schwarer and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Bik To

18 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bik To Australia 10 169 159 127 91 80 18 424
Y.S. Chae South Korea 11 194 1.1× 120 0.8× 37 0.3× 47 0.5× 121 1.5× 41 412
Sue Corringham United States 10 364 2.2× 214 1.3× 255 2.0× 118 1.3× 42 0.5× 25 554
Elizabeth L. Courville United States 11 147 0.9× 136 0.9× 64 0.5× 108 1.2× 25 0.3× 46 376
Lokanatha Dasappa India 9 106 0.6× 44 0.3× 47 0.4× 52 0.6× 40 0.5× 41 257
J.L. Pico France 7 203 1.2× 110 0.7× 24 0.2× 130 1.4× 153 1.9× 10 408
S. Giralt United States 5 218 1.3× 325 2.0× 95 0.7× 37 0.4× 50 0.6× 18 486
Laura Stephanie Miller United States 7 187 1.1× 225 1.4× 63 0.5× 50 0.5× 44 0.6× 11 408
László Váróczy Hungary 13 85 0.5× 64 0.4× 89 0.7× 223 2.5× 36 0.5× 47 425
Öner Doğan Türkiye 11 128 0.8× 61 0.4× 33 0.3× 127 1.4× 51 0.6× 56 404
Jadwiga Małdyk Poland 12 108 0.6× 51 0.3× 87 0.7× 267 2.9× 111 1.4× 33 463

Countries citing papers authored by Bik To

Since Specialization
Citations

This map shows the geographic impact of Bik To's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bik To with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bik To more than expected).

Fields of papers citing papers by Bik To

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bik To. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bik To. The network helps show where Bik To may publish in the future.

Co-authorship network of co-authors of Bik To

This figure shows the co-authorship network connecting the top 25 collaborators of Bik To. A scholar is included among the top collaborators of Bik To based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bik To. Bik To is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pettengell, Ruth, Ariane Boumendil, Bernd Metzner, et al.. (2017). DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL. Hematological Oncology. 35(S2). 32–33. 5 indexed citations
2.
3.
Howie, Donald W., et al.. (2015). Anaemia in elective orthopaedic surgery – Royal Adelaide Hospital, Australia. Internal Medicine Journal. 46(1). 96–101. 7 indexed citations
4.
5.
Weber, N, Peter Mollee, Ross Brown, et al.. (2014). Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal. 45(4). 371–382. 19 indexed citations
6.
Hiwase, Devendra, Christopher N Hahn, Milena Babic, et al.. (2014). Clonal Diversity of Recurrently Mutated Genes in Myelodysplastic Syndromes. Blood. 124(21). 4634–4634. 3 indexed citations
7.
8.
9.
Guthridge, Mark A., Jason A. Powell, Emma F. Barry, et al.. (2006). Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. The EMBO Journal. 25(3). 479–489. 65 indexed citations
10.
Luke, Colin, Anh Minh Nguyen, Bik To, et al.. (2006). Myeloid leukaemia treatment and survival--the South Australian experience, 1977 to 2002.. PubMed. 7(2). 227–33. 11 indexed citations
11.
Wirth, A., H. Miles Prince, M Wolf, et al.. (2004). Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study. Bone Marrow Transplantation. 35(3). 291–298. 11 indexed citations
12.
Mullighan, Charles G., Susan L. Heatley, Kathleen Doherty, et al.. (2004). Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation. 77(4). 587–596. 71 indexed citations
13.
Borbasi, Sally, et al.. (2002). More Than a Sore Mouth: Patients' Experience of Oral Mucositis. Oncology nursing forum. 29(7). 1051–1057. 63 indexed citations
14.
To, Bik. (2002). Dacie and Lewis Practical Haematology: Ninth Edition. Pathology. 34(5). 485–485. 2 indexed citations
15.
To, Bik, et al.. (2000). Haematemesis resulting from ischaemic strangulating intestinal obstruction. European Journal of Emergency Medicine. 7(4). 297–299. 2 indexed citations
16.
17.
18.
Horvath, N., Joanne Bayly, J. Q. K. Ho, et al.. (1996). An incremental response to high-dose therapy in multiple myeloma.. PubMed. 17(6). 929–35. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y.S. Chae Breakdown of academic impact, for papers by Sue Corringham Breakdown of academic impact, for papers by Elizabeth L. Courville Breakdown of academic impact, for papers by Lokanatha Dasappa Breakdown of academic impact, for papers by J.L. Pico Breakdown of academic impact, for papers by S. Giralt Breakdown of academic impact, for papers by Laura Stephanie Miller Breakdown of academic impact, for papers by László Váróczy Breakdown of academic impact, for papers by Öner Doğan Breakdown of academic impact, for papers by Jadwiga Małdyk
Rankless by CCL
2026